The Research Working Group seeks to bridge the missing mile between basic research and the commercialization of products. Having an equal partnership between the Virtual Physiological Human Institute (VPH) and industries engaged in predictive medicine provides a unique opportunity to explore areas of mutual cooperation and benefit.

The key goals of this group are:

  • Promotion of in silico medicine in Horizon 2020;
  • Working towards the creation of a Public Private Partnership (PPP) on in silico medicine;
  • Creating links between the VPH Membership and Avicenna Industry Members


Priorities in 2018

→ Further develop a comprehensive position for Avicenna on what is needed in EU research;
→ Launch of the new Avicenna Alliance internship scheme;
→ A core focus of the VPH membership is on the FET Flagship on ageing and on shaping this Flagship programme;
→ Contribute to the three upcoming Avicenna Alliance White Papers

Working group leader:

  • Liesbet Geris
  • Executive Director, VPH Institute
  • Professor, University of Liège & KU Leuven (Belgium)

Avicenna Alliance news

Commission participates  to international In Silico Toxicology Protocol initiative

The European Commission’s Joint Research Center (JRC) Directorate published on 22 November an article highlighting...

find out more ›

Health Tech Industry roundtable meeting discussed EU Digital Health Agenda

On 15 October, a high-level roundtable meeting, organised by European Commissioner for Digital Economy and Society Mariya...

find out more ›

EU invests €1 billion in world-class European supercomputers

The Competitiveness Council (Council of Ministers) of the European Union adopted a Regulation to establish a Joint Undertaking of European...

find out more ›

Show all activites